Form D · Other Health Care
Anodyne Nanotech, Inc.
Boston, MA · CIK 0001818572
Offering snapshot reported Jun 11, 2026 · SEC filing
- Reported sold
- $12.6M Offering amount: $17.3M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2026 | Initial | $12,597,058 | No comparison | 47 | SEC filing |
| May 7, 2021 | Amendment | $1,957,280 | $242,280vs Feb 25, 2021 | 15 | SEC filing |
| Feb 25, 2021 | Initial | $1,715,000 | No comparison | 6 | SEC filing |
| Aug 7, 2020 | Initial | $1,469,417 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-587017
Source: Form D, filed Jun 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Achilleas Gravanis | Director |
| Lombardo Jake | Executive |
| Lampros Kourtis | Director |
| Vikram Lamba | Director |
| Jake Lombardo | Director, Executive |
| Georgios Papastergiou | Director |
| Hojatollah Rezaei Nejad | Executive |
| Michael Singer | Director |
| Konstantinos Tzortzakis | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
38 Wareham Street, 3rd Floor
Boston, MA, 02118
Boston, MA, 02118